CA1035281A - Pharmaceutical compositions for inhibiting absorption of cholesterol - Google Patents

Pharmaceutical compositions for inhibiting absorption of cholesterol

Info

Publication number
CA1035281A
CA1035281A CA215,873A CA215873A CA1035281A CA 1035281 A CA1035281 A CA 1035281A CA 215873 A CA215873 A CA 215873A CA 1035281 A CA1035281 A CA 1035281A
Authority
CA
Canada
Prior art keywords
cholesterol
pharmaceutical compositions
inhibiting absorption
inhibiting
absorption
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA215,873A
Other languages
English (en)
French (fr)
Inventor
Fred H. Mattson
Robert A. Volpenhein
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Application granted granted Critical
Publication of CA1035281A publication Critical patent/CA1035281A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H13/00—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids
    • C07H13/02—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids
    • C07H13/04—Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids by carboxylic acids having the esterifying carboxyl radicals attached to acyclic carbon atoms
    • C07H13/06—Fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
CA215,873A 1973-12-14 1974-12-12 Pharmaceutical compositions for inhibiting absorption of cholesterol Expired CA1035281A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/425,010 US3954976A (en) 1973-12-14 1973-12-14 Pharmaceutical compositions for inhibiting absorption of cholesterol

Publications (1)

Publication Number Publication Date
CA1035281A true CA1035281A (en) 1978-07-25

Family

ID=23684766

Family Applications (1)

Application Number Title Priority Date Filing Date
CA215,873A Expired CA1035281A (en) 1973-12-14 1974-12-12 Pharmaceutical compositions for inhibiting absorption of cholesterol

Country Status (11)

Country Link
US (1) US3954976A (nl)
AU (1) AU498290B2 (nl)
BE (1) BE823345A (nl)
CA (1) CA1035281A (nl)
DE (1) DE2458732C2 (nl)
FR (1) FR2254318B1 (nl)
GB (1) GB1450308A (nl)
IE (1) IE40307B1 (nl)
NL (1) NL182618C (nl)
PH (1) PH10477A (nl)
ZA (1) ZA747923B (nl)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4034083A (en) * 1975-11-03 1977-07-05 The Procter & Gamble Company Compositions for inhibiting absorption of cholesterol
USRE33885E (en) * 1975-11-03 1992-04-14 The Procter & Gamble Company Compositions for inhibiting absorption of cholesterol
US4005196A (en) * 1976-02-12 1977-01-25 The Procter & Gamble Company Vitaminized compositions for treating hypercholesterolemia
US4005195A (en) * 1976-02-12 1977-01-25 The Procter & Gamble Company Compositions for treating hypercholesterolemia
IE44458B1 (en) * 1976-02-12 1981-12-02 Procter & Gamble Compositions for treating hypercholesterolemia
USRE33996E (en) * 1976-02-12 1992-07-14 The Procter & Gamble Company Compositions for treating hypercholesterolemia
US4264583A (en) * 1979-07-25 1981-04-28 The Procter & Gamble Company Gallstone dissolution compositions and method
DE3249304T1 (de) * 1981-12-25 1983-12-15 Mitsui Toatsu Chemicals, Inc., Tokyo Mittel zum verhindern oder behandeln von blaehungen
US5597810A (en) 1984-12-27 1997-01-28 Hoffman; Allan S. Method for reducing absorption of undesired lipids in the gastrointestinal tract
US4705690A (en) * 1985-11-18 1987-11-10 The Procter & Gamble Co. Weighting oil substitutes
DE3761050D1 (de) * 1986-02-19 1990-01-04 Unilever Nv Fettsaeureester von zuckern und zuckeralkoholen.
DE3788443T2 (de) * 1986-02-20 1994-04-28 Procter & Gamble Kalorienarme Fettprodukte, die die laxierenden Nebeneffekte ausschliessen.
EP0233856B1 (en) * 1986-02-20 1994-01-05 The Procter & Gamble Company Better tasting low calorie fat materials
EP0236288B1 (en) * 1986-02-20 1993-12-15 The Procter & Gamble Company Low calorie fat materials that eliminate laxative side effect
US4789664A (en) * 1986-12-19 1988-12-06 The Procter & Gamble Company Food compositions with superior blood cholesterol lowering properties
US4806632A (en) * 1986-12-29 1989-02-21 The Procter & Gamble Company Process for the post-hydrogenation of sucrose polyesters
US4849222A (en) * 1987-03-24 1989-07-18 The Procter & Gamble Company Mixtures for treating hypercholesterolemia
US4880657A (en) * 1987-05-06 1989-11-14 The Procter & Gamble Company Shortening compositions containing polyol polyesters
US4962092A (en) * 1987-05-06 1990-10-09 The Procter & Gamble Company Compositions for treating duodenal ulcers
US5124166A (en) * 1987-08-13 1992-06-23 Nabisco, Inc. Carboxy/carboxylate disubstituted esters as edible fat mimetics
US4830787A (en) * 1987-08-13 1989-05-16 Nabisco Brands, Inc. Low calorie fat mimetics comprising carboxy/carboxylate esters
ES2022597B3 (es) * 1987-08-19 1991-12-01 Unilever Nv Producto comestible que contiene grasa y procedimiento para su produccion.
ES2026642T3 (es) * 1987-08-19 1992-05-01 Unilever Nv Producto comestible que contiene grasa.
US4835001A (en) * 1987-09-09 1989-05-30 The Proctor & Gamble Company Baked goods made with sucrose fatty acid esters
US5095008A (en) * 1987-09-14 1992-03-10 The Procter & Gamble Company Cookies containing psyllium
US4950140A (en) * 1987-09-14 1990-08-21 The Procter & Gamble Company Cookies containing psyllium
US5116610A (en) * 1987-12-29 1992-05-26 The Procter & Gamble Company Compositions for treating hypercholesterolemia
US5910317A (en) * 1988-01-11 1999-06-08 The Procter & Gamble Company Mixed compositions for treating hypercholesterolemia
US5041541A (en) * 1988-05-05 1991-08-20 The Procter & Gamble Company Functional sugar substituted with reduced calories
US5104797A (en) * 1988-05-05 1992-04-14 The Procter & Gamble Company Process for preparing 5-c-hydroxymethyl aldohexose-based compounds
US5106967A (en) * 1988-05-05 1992-04-21 The Procter & Gamble Company Functional sugar substitutes with reduced calories
US5064672A (en) * 1988-05-05 1991-11-12 The Procter & Gamble Company Functional sugar substitutes with reduced calories
US5370894A (en) * 1988-06-24 1994-12-06 The Nutrasweet Company Carbohydrate cream substitute
US5006360B1 (en) * 1988-06-27 1992-04-28 Low calorie fat substitute compositions resistant to laxative side effect
US4925692A (en) * 1988-11-07 1990-05-15 Dow Corning Corporation Food composition containing a siloxane polymer and a particulate silica
US5023106A (en) * 1989-03-28 1991-06-11 The Procter & Gamble Co. Process for tempering flavored confectionery compositions containing reduced calorie fats and resulting tempered products
CA2025314A1 (en) * 1989-10-12 1991-04-13 Ronald J. Jandacek Triglycerides containing saturated fatty acids having 20 to 24 carbon atoms useful in lowering blood cholesterol levels
US5126150A (en) * 1990-10-01 1992-06-30 The Procter & Gamble Company Compositions containing psyllium
US5502045A (en) 1991-05-03 1996-03-26 Raision Tehtaat Oy Ab Use of a stanol fatty acid ester for reducing serum cholesterol level
US5244887A (en) * 1992-02-14 1993-09-14 Straub Carl D Stanols to reduce cholesterol absorption from foods and methods of preparation and use thereof
US5424420A (en) * 1993-10-05 1995-06-13 Kraft Foods, Inc. Method for preparing saccharide polyesters by transesterification
US5440027A (en) * 1993-10-05 1995-08-08 Kraft General Foods, Inc. Method for preparing saccharide fatty acid polyesters by transesterification
US5596085A (en) * 1995-04-11 1997-01-21 Kraft Foods, Inc. Method for preparing polyol fatty acid polyesters by transesterification
US5968566A (en) * 1996-05-14 1999-10-19 Mlp Operating Company Refrigerated yeast-raised pizza dough
UA69378C2 (uk) * 1996-11-04 2004-09-15 Райзіо Бенекол Лтд. Текстуруюча композиція, текстуруючий агент, харчовий продукт, жирові суміші та способи їх одержання
US6929816B2 (en) 1998-01-21 2005-08-16 Raisio Benecol Ltd. Fat compositions for use in food
US6361817B1 (en) 1999-12-17 2002-03-26 Bestfoods Low calorie nut butters
US7763587B2 (en) * 2002-06-13 2010-07-27 L'oreal S.A. Derivative of glucose and of vitamin F, compositions comprising it, uses and preparation process
WO2007064740A2 (en) * 2005-12-02 2007-06-07 The Coca-Cola Company Reduced calorie frozen beverage
US20090163452A1 (en) * 2007-12-20 2009-06-25 Schwartz Janice B Compositions and methods for lowering serum cholesterol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL111638C (nl) * 1955-12-12
US2962419A (en) * 1957-05-20 1960-11-29 Heyden Newport Chemical Corp Dietetic compositions
US3093481A (en) * 1961-04-18 1963-06-11 Procter & Gamble Plastic glyceride fat and process for preparing it
US3849554A (en) * 1965-12-01 1974-11-19 Nasa Reduction of blood serum cholesterol
US3600186A (en) * 1968-04-23 1971-08-17 Procter & Gamble Low calorie fat-containing food compositions

Also Published As

Publication number Publication date
AU498290B2 (en) 1979-03-01
IE40307L (en) 1975-06-14
FR2254318A1 (nl) 1975-07-11
ZA747923B (en) 1975-12-31
NL7416254A (nl) 1975-06-17
DE2458732A1 (de) 1975-06-26
NL182618C (nl) 1988-04-18
PH10477A (en) 1977-05-11
GB1450308A (en) 1976-09-22
FR2254318B1 (nl) 1978-07-21
NL182618B (nl) 1987-11-16
BE823345A (fr) 1975-06-13
DE2458732C2 (de) 1983-01-20
US3954976A (en) 1976-05-04
AU7647474A (en) 1976-06-17
IE40307B1 (en) 1979-04-25

Similar Documents

Publication Publication Date Title
CA1035281A (en) Pharmaceutical compositions for inhibiting absorption of cholesterol
CA1030871A (en) Pharmaceutical compositions
CA1026673A (en) Pharmaceutical compositions
CA1012065A (en) Pharmaceutical compositions for stimulation of cardiovascular functions containing the antibiotic x-537a and its derivatives
AU498989B2 (en) Pharmaceutical compositions
AU1376576A (en) Xanthine-containing pharmaceutical compositions
IL44794A0 (en) Pharmaceutical compositions containing certain triazolyl derivatives
ZA742956B (en) Pharmaceutical compositions containing triazolo-isoquinoline derivatives
CA1024892A (en) Pharmaceutical compositions containing triazolo-isoquinoline derivatives
CA1030451A (en) Pharmaceutical composition for the treatment of coronaric aliments
CA1028247A (en) Pharmaceutical compositions containing p-hydroxyacetanilide
AU498557B2 (en) D-homosteroids & pharmaceutical compositions
AU499440B2 (en) Pharmaceutical compositions containing 2-naphthylbutyric acid derivatives
CA971481A (en) Pharmaceutical compositions containing benzofuran derivatives
AU499217B2 (en) Pharmaceutical compositions
IL44471A (en) Pharmaceutical compositions containing nitro-acetophenone derivatives certain new such compounds and their preparation
AU480639B2 (en) Pharmaceutical compositions containing triazolo-isoquinoline derivatives
IL41923A0 (en) Preparation of derivatives of cholesterol
AU494300B2 (en) Pharmaceutical compositions
AU485568B2 (en) Pharmaceutical compositions
AU492729B2 (en) Pharmaceutical compositions
AU478769B2 (en) Pharmaceutical compositions
AU493221B2 (en) Pharmaceutical compositions
CA1024161A (en) Process for the preparation of alkylsulfonated compounds
CA1012144A (en) Synthesis for the preparation of 3-hydroxy-n-alkylisomorphinans